Zhisong He
- Genetics top 10%
- Mesenchymal stem cell research 6
-
- Tissue Engineering and Regenerative Medicine 5
-
- Congenital heart defects research 3
- RNA modifications and cancer 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Prostate Cancer Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Co-authors
- Meifeng XuHongxia LiZeeshan PashaYigang WangMuhammad AshrafBin YuXiangjun YangW. Keith Jones
- Cited by
- GeneticsBiomaterialsCancer Research
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Zhisong He
16 papers receiving 335 citations
Peers
Comparison fields: 5 of 69
- Genetics 132
- Biomaterials 80
- Cancer Research 58
- Surgery 157
- Family Practice 7
Countries citing papers authored by Zhisong He
This map shows the geographic impact of Zhisong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhisong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhisong He more than expected).
Fields of papers citing papers by Zhisong He
This network shows the impact of papers produced by Zhisong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhisong He. The network helps show where Zhisong He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhisong He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 17 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 21 | |
| 9 | 2019 | 6 | |
| 10 | 2013 | 22 | |
| 11 | 2011 | 43 | |
| 12 | 2011 | 33 | |
| 13 | 2011 | 32 | |
| 14 | 2011 | 3 | |
| 15 | 2010 | 126 | |
| 16 | 2009 | 5 |
About Zhisong He
Zhisong He is a scholar working on Genetics, Biomaterials and Speech and Hearing, having authored 16 papers that have together received 339 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), Congenital heart defects research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers), RNA modifications and cancer (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Genetics (132 citations), Biomaterials (80 citations) and Cancer Research (58 citations). Zhisong He has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Meifeng Xu, Hongxia Li, Zeeshan Pasha, Yigang Wang, Muhammad Ashraf, Bin Yu, Xiangjun Yang, Muhammad Ashraf, W. Keith Jones and Wen‐Ping Jiang. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.